Open AccessP1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS
Author(s) -
DeAngelo D. J.,
Pullarkat V.,
PirisVillaespesa M.,
George T. I.,
Patel J. L.,
Ustun C.,
Bose P.,
Heaney M. L.,
Pilla A.,
Massaro M.,
Exter B.,
Jolin H. A.,
Mikhak Z.,
Tashi T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847064.38588.9b
Subject(s) - systemic mastocytosis , medicine , tyrosine kinase inhibitor , mast cell , clinical trial , phases of clinical research , oncology , cutaneous mastocytosis , bone marrow , pathology , immunology , cancer